PHASE 2 STUDY OF PD-1 BLOCKADE WITH PEMBROLIZUMAB PLUS RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA (RGBM) (NCT03661723)

Authors
Category Primary study
JournalNeuro-Oncology
Year 2022
This article has no abstract
Epistemonikos ID: bfb76f2863994dcade03d71e0996e8c6ee78519b
First added on: Feb 15, 2025